Fortress Biotech, Inc. (FBIO)
2.52
-0.05
(-1.95%)
USD |
NASDAQ |
Sep 11, 16:00
2.535
+0.02
(+0.60%)
After-Hours: 20:00
Fortress Biotech Market Cap : 83.94M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 83.94M |
| September 10, 2026 | 85.61M |
| September 09, 2026 | 87.61M |
| September 08, 2026 | 90.27M |
| September 04, 2026 | 90.61M |
| September 03, 2026 | 90.27M |
| September 02, 2026 | 90.94M |
| September 01, 2026 | 89.27M |
| August 31, 2026 | 91.11M |
| August 28, 2026 | 92.27M |
| August 27, 2026 | 93.27M |
| August 26, 2026 | 93.60M |
| August 25, 2026 | 94.27M |
| August 24, 2026 | 97.60M |
| August 21, 2026 | 95.60M |
| August 20, 2026 | 92.27M |
| August 19, 2026 | 94.94M |
| August 18, 2026 | 96.94M |
| August 17, 2026 | 93.94M |
| August 14, 2026 | 97.60M |
| August 13, 2026 | 99.27M |
| August 12, 2026 | 91.61M |
| August 11, 2026 | 86.94M |
| August 10, 2026 | 91.26M |
| August 07, 2026 | 88.61M |
| Date | Value |
|---|---|
| August 06, 2026 | 91.93M |
| August 05, 2026 | 92.59M |
| August 04, 2026 | 90.27M |
| August 03, 2026 | 91.60M |
| July 31, 2026 | 103.87M |
| July 30, 2026 | 109.18M |
| July 29, 2026 | 111.18M |
| July 28, 2026 | 112.50M |
| July 27, 2026 | 108.52M |
| July 24, 2026 | 110.84M |
| July 23, 2026 | 113.83M |
| July 22, 2026 | 117.81M |
| July 21, 2026 | 117.15M |
| July 20, 2026 | 110.51M |
| July 17, 2026 | 111.51M |
| July 16, 2026 | 113.50M |
| July 15, 2026 | 123.12M |
| July 14, 2026 | 123.79M |
| July 13, 2026 | 109.52M |
| July 10, 2026 | 109.52M |
| July 09, 2026 | 109.18M |
| July 08, 2026 | 99.56M |
| July 07, 2026 | 99.23M |
| July 06, 2026 | 97.90M |
| July 02, 2026 | 100.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 102.93M |
| Kura Oncology, Inc. | 1.013B |
| Spero Therapeutics, Inc. | 65.71M |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
Market Cap Related Metrics
| PE Ratio | 0.9486 |
| PS Ratio | 1.239 |
| Price to Book Value | 0.5114 |
| Price to Free Cash Flow | 0.7054 |
| Price | 2.52 |
| Earnings Yield | 105.4% |
| Normalized PE Ratio | 1.029 |